Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

US Patent 11390651 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Laser assisted machining of sheet material2025
Recombinant metapneumovirus f proteins and their use2025
Recombinant metapneumovirus f proteins and their use2025
Recombinant virus with codon-pair deoptimized region and uses thereof for the tr2024
Attenuated flaviviruses2024
Method of vaccination with an attenuated RSV vaccine formulation2024
Method of vaccination with an attenuated RSV vaccine formulation2024
Methods for moisture removal and pest control of grains2024
Transceiver device2024
Chimeric vectors2024
Chimeric vectors2024
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated2024